Association for Accessible Medicines sues to block California pay-for-delay bill
MLex Summary: The Association for Accessible Medicines filed a suit challenging California’s new law to make pay-for-delay agreements between branded and generic pharmaceutical companies presumptively anticompetitive. AAM says that the legislation...To view the full article, register now.
Already a subscriber? Click here to view full article